D-Amino Acid Prodrug DLMEH Activates mTORC1 via Sestrin2 to Restore Muscle Protein Synthesis in Sarcopenia.
What this study shows
DLMEH, a D-leucine ester prodrug, binds Sestrin2 with leucine-like potency and improved pharmacokinetics, activating mTORC1 to restore muscle protein synthesis and muscle mass/function in a sarcopenia model — a mechanistic and pharmacological advance on the amino-acid-sensing (Sestrin2→mTORC1) axis.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse sarcopenia model); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse sarcopenia model |
| Journal | Molecular Therapy |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-08-22 |
| Source | DOI 10.1016/j.ymthe.2026.09.007 · PMID 42723280 |